Rockwell Automation, Inc. · ROK · FY2026 Q2 · Calendar Q2 2026
Rockwell Automation Beats Revenue and EPS, Raises FY2026 Guidance on Data Center Demand
Rockwell Automation's Q2 FY2026 results showed broad-based strength, with 12% reported sales growth, a 22.5% enterprise operating margin, and adjusted EPS of $3.30 beating the $2.88 consensus by 14.6%. Revenue of $2.24B exceeded the $2.16B estimate by 3.7%. The company raised full-year guidance, with organic sales growth now 5-9% and adjusted EPS midpoint at $12.80, up from $11.80 in Q1. Demand accelerated in data centers, semiconductor, e-commerce/warehouse automation, and energy, while tariffs and memory cost inflation remain managed headwinds. The market reacted strongly, with the stock up 8.9% on the report session and continuing to drift 5.9% higher subsequently on 2.76x normal volume.
Company context
Snapshot as of publicationRockwell Automation, Inc., established in 1903 and headquartered in Milwaukee, Wisconsin, is a global leader in providing industrial automation and digital transformation solutions. The company's operations are segmented into three key areas: Intelligent Devices, Software & Control, and Lifecycle Services. The Intelligent Devices segment offers various hardware products such as drives, motion control systems, safety and sensing equipment, industrial components, and customized configurations. The Software & Control division provides essential control and visualization software and accompanying hardware, information management platforms, digital twin and simulation tools, and network and cybersecurity infrastructure.…
Earnings scorecard
Reported versus consensusEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Jul 13, 2026 |
| TD Cowen | Hold | Hold | Maintain | May 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 6, 2026 |
| Keybanc | Overweight | Overweight | Maintain | May 6, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 6, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 6, 2026 |
| Jefferies | Hold | Buy | Downgrade | Mar 31, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 30, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Feb 6, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Jan 20, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 13, 2026 |
| Goldman Sachs | Neutral | Sell | Upgrade | Dec 16, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 20, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Jul 16, 2025 |
| Loop Capital | Hold | Hold | Maintain | May 15, 2025 |
| UBS | Neutral | Buy | Downgrade | Nov 13, 2024 |
| Berenberg | Hold | Buy | Downgrade | Mar 6, 2024 |
| Daiwa Capital | Buy | Outperform | Maintain | Feb 1, 2024 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Jul 11, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| Cowen & Co. | Underperform | Underperform | Maintain | Jan 30, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Nov 3, 2022 |
| Argus Research | Buy | Buy | Maintain | Aug 17, 2022 |
| HSBC | Hold | Hold | Maintain | May 10, 2022 |
| Bernstein | Outperform | Outperform | Maintain | Jan 11, 2022 |
| Rosenblatt | Neutral | Neutral | Maintain | May 3, 2021 |
| Gordon Haskett | Buy | Hold | Upgrade | Mar 25, 2020 |
| Gabelli & Co. | Hold | Buy | Downgrade | Nov 13, 2019 |
| Bank of America | Neutral | Neutral | Maintain | Nov 13, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 26, 2019 |
| Vertical Research | Hold | Buy | Downgrade | Apr 26, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 26, 2018 |
| Stifel | Hold | Hold | Maintain | Apr 26, 2018 |
| FBR Capital | Perform | Market Perform | Maintain | May 11, 2016 |
| Ladenburg Thalmann | Hold | Buy | Downgrade | Apr 28, 2016 |
| CLSA | Underperform | Outperform | Downgrade | Nov 11, 2015 |
| Nomura | Neutral | Neutral | Maintain | Sep 17, 2015 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 5, 2014 |
| BB&T Capital | Hold | Hold | Maintain | Dec 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $459.39. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Chris Dankert | $500 | $463.57 | +8.8% | Jun 15, 2026 |
| Bernstein | Analyst unavailable | $501 | $460.47 | +9.1% | Jun 9, 2026 |
| Mizuho Securities | Brett Linzey | $445 | $435.93 | -3.1% | May 6, 2026 |
| KeyBanc | Analyst unavailable | $510 | $435.93 | +11.0% | May 6, 2026 |
| Morgan Stanley | Christopher Snyder | $525 | $435.93 | +14.3% | May 6, 2026 |
| Barclays | Analyst unavailable | $480 | $435.93 | +4.5% | May 6, 2026 |
| Morgan Stanley | Analyst unavailable | $460 | $415.02 | +0.1% | Feb 8, 2026 |
| KeyBanc | Analyst unavailable | $470 | $418.1 | +2.3% | Feb 6, 2026 |
| Robert W. Baird | Analyst unavailable | $430 | $418.45 | -6.4% | Feb 6, 2026 |
| Mizuho Securities | Analyst unavailable | $400 | $406.7 | -12.9% | Feb 6, 2026 |
| Barclays | Analyst unavailable | $450 | $413.36 | -2.0% | Jan 7, 2026 |
| Wells Fargo | Joseph O'Dea | $410 | $413.36 | -10.8% | Jan 7, 2026 |
| Goldman Sachs | Joe Ritchie | $448 | $401.78 | -2.5% | Dec 16, 2025 |
| Jefferies | Analyst unavailable | $470 | $400.61 | +2.3% | Dec 10, 2025 |
| Robert W. Baird | Analyst unavailable | $402 | $371.26 | -12.5% | Nov 21, 2025 |
| Oppenheimer | Noah Kaye | $391 | $366.53 | -14.9% | Nov 7, 2025 |
| Oppenheimer | Analyst unavailable | $365 | $340.46 | -20.5% | Oct 14, 2025 |
| Barclays | Julian Mitchell | $370 | $349.01 | -19.5% | Aug 14, 2025 |
| Wells Fargo | Joseph O'Dea | $345 | $332.59 | -24.9% | Aug 8, 2025 |
| KeyBanc | Ken Newman | $380 | $336.49 | -17.3% | Aug 7, 2025 |
| Barclays | Julian Mitchell | $280 | $269.28 | -39.0% | Mar 26, 2025 |
| Barclays | Julian Mitchell | $285 | $281.31 | -38.0% | Jan 8, 2025 |
| KeyBanc | Ken Newman | $345 | $295.42 | -24.9% | Dec 9, 2024 |
| Morgan Stanley | Chris Snyder | $320 | $256.92 | -30.3% | Sep 6, 2024 |
| Bank of America Securities | Andrew Obin | $270 | $249.16 | -41.2% | Aug 8, 2024 |
| Oppenheimer | Noah Kaye | $270 | $249.16 | -41.2% | Aug 8, 2024 |
| Mizuho Securities | Brett Linzey | $245 | $249.16 | -46.7% | Aug 8, 2024 |
| Redburn Partners | Richard Radbourne | $256 | $264.07 | -44.3% | Jul 8, 2024 |
| Loop Capital Markets | Chris Dankert | $290 | $268.92 | -36.9% | May 14, 2024 |
| Jefferies | Saree Boroditsky | $280 | $272.04 | -39.0% | May 7, 2024 |
| Daiwa | Jairam Nathan | $310 | $263.01 | -32.5% | Feb 1, 2024 |
| Wells Fargo | Joseph O'Dea | $357 | $305.3 | -22.3% | Dec 19, 2023 |
| Oppenheimer | Noah Kaye | $300 | $283.41 | -34.7% | Apr 28, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $335 | $293.65 | -27.1% | Feb 14, 2023 |
| Morgan Stanley | Analyst unavailable | $284 | $265.9 | -38.2% | Jan 6, 2023 |
| Wells Fargo | Analyst unavailable | $233 | $259.74 | -49.3% | Jan 5, 2023 |
| Goldman Sachs | Analyst unavailable | $238 | $256.59 | -48.2% | Dec 15, 2022 |
| Citigroup | Analyst unavailable | $297 | $259.81 | -35.3% | Dec 9, 2022 |
| Barclays | Analyst unavailable | $206 | $222.51 | -55.2% | Oct 3, 2022 |
| Argus Research | Analyst unavailable | $290 | $254.4 | -36.9% | Aug 17, 2022 |
| Credit Suisse | Analyst unavailable | $246 | $238.55 | -46.5% | Jul 28, 2022 |
| Wells Fargo | Analyst unavailable | $213 | $240.46 | -53.6% | Jul 28, 2022 |
| Citigroup | Analyst unavailable | $274 | $240.46 | -40.4% | Jul 28, 2022 |
| Mizuho Securities | Analyst unavailable | $200 | $206.35 | -56.5% | Jul 18, 2022 |
| Deutsche Bank | Analyst unavailable | $212 | $194.01 | -53.9% | Jul 13, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $260 | $200.01 | -43.4% | Jul 6, 2022 |
| Wells Fargo | Analyst unavailable | $190 | $197.64 | -58.6% | Jun 29, 2022 |
| Barclays | Analyst unavailable | $200 | $195.43 | -56.5% | May 24, 2022 |
| Stephens | Analyst unavailable | $250 | $218.21 | -45.6% | May 4, 2022 |
| Morgan Stanley | Analyst unavailable | $325 | $217.68 | -29.3% | May 4, 2022 |
| Credit Suisse | Analyst unavailable | $256 | $217.48 | -44.3% | May 4, 2022 |
| Citigroup | Analyst unavailable | $310 | $219.78 | -32.5% | May 4, 2022 |
| Barclays | Analyst unavailable | $220 | $213.74 | -52.1% | May 4, 2022 |
| Robert W. Baird | Robert Mason | $310 | $217.17 | -32.5% | May 4, 2022 |
| Goldman Sachs | Joe Ritchie | $294 | $284.6 | -36.0% | Jan 28, 2022 |
| Bernstein | Brendan Luecke | $378 | $328.82 | -17.7% | Jan 10, 2022 |
| Deutsche Bank | Nicole Deblase | $340 | $328.82 | -26.0% | Jan 10, 2022 |
| Argus Research | John Eade | $390 | $341.24 | -15.1% | Dec 14, 2021 |
| Berenberg Bank | Phil Buller | $390 | $343.55 | -15.1% | Nov 24, 2021 |
| Loop Capital Markets | Chris Dankert | $315 | $340.57 | -31.4% | Nov 17, 2021 |
| UBS | Markus Mittermaier | $338 | $336.49 | -26.4% | Nov 5, 2021 |
| Oppenheimer | Noah Kaye | $360 | $336.78 | -21.6% | Nov 3, 2021 |
| Stephens | Robert McCarthy | $300 | $295.96 | -34.7% | Jul 28, 2021 |
| HSBC | Puneet Garg | $285 | $290.66 | -38.0% | Jul 15, 2021 |
| Cowen & Co. | Joseph C Giordano | $205 | $257.32 | -55.4% | May 3, 2021 |
Track every rating change on ROK the moment it posts. Free to start.
Start freeMarket reaction
prior-close to event-session closeFollow ROK with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Guidance raised: adjusted EPS midpoint moved from $11.80 to $12.80; organic sales growth updated to 5-9%. New demand verticals emerged with data center automation and semiconductor joining earlier growth drivers. Sensia joint venture dissolution completed, returning process automation to full Rockwell control. New partnerships disclosed with BHP for autonomous operations and NASA Artemis II ground control systems. OTTO autonomous mobile robots and Fix cloud software became prominent growth drivers alongside the established Logix PLC platform.
Guidance delta
Full-year FY2026 adjusted EPS guidance midpoint raised from $11.80 (Q1) to $12.80 (Q2). Organic sales growth guidance set at 5-9%. Guidance sentiment was raised in both consecutive quarters.
Key takeaways
- Q2 results beat expectations with 12% reported sales growth and 22.5% enterprise operating margin
- Full-year guidance raised: organic sales growth 5-9% and adjusted EPS midpoint $12.80
- Margins expanding across Intelligent Devices and Software & Control, driven by volume, pricing and productivity
- Demand acceleration in data centers, semiconductor, e-commerce/warehouse automation, and energy
- Cost pressures from memory, tariffs and commodity inflation are being managed through pricing actions and safety stock
Management priorities
- Launch of new products at upcoming Automation Fair
- Continued rollout of AI and cloud-native software solutions
- Expansion of autonomous mobile robot deployments (e.g., Subaru, BHP)
- Further integration of Sensia assets into Rockwell's process automation portfolio
- Scaling digital maintenance platform Fix with new enterprise wins
Related earnings events
IndustrialsSources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-29T22:01:23.381631+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-29T22:01:23.378961+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.